- Home
- PSBD vs SOPH Comparison
PSBD vs SOPH Comparison
Compare PSBD & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PSBD | SOPH |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 386.6M | 330.4M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PSBD | SOPH |
|---|---|---|
| Price | $12.01 | $5.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $13.30 | $7.00 |
| AVG Volume (30 Days) | ★ 140.7K | 60.2K |
| Earning Date | 02-26-2026 | 11-04-2025 |
| Dividend Yield | ★ 13.78% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,297,000.00 |
| Revenue This Year | N/A | $18.32 |
| Revenue Next Year | N/A | $15.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $11.51 | $2.58 |
| 52 Week High | $16.16 | $5.30 |
Technical Indicators
Market Signals| Indicator | PSBD | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 46.90 | 67.60 |
| Support Level | $11.86 | $4.52 |
| Resistance Level | $12.28 | $5.05 |
| Average True Range (ATR) | 0.23 | 0.22 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 44.34 | 94.44 |
Price Performance
Historical ComparisonAbout PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.